The pan-European, academic & private sector GLIORESOLVE Doctoral Network (DN) is funded by the European Union’s Horizon Europe programme under the Marie Skłodowska-Curie DN initiative. The project started in 2022 and over the next four years, will train 10 innovative, creative and entrepreneurial PhD students with a specific focus on GBM research. Overall, GLIORESOLVE provides a comprehensive translational research strategy that goes significantly beyond the current state-of-the-art in neuro-oncology, to establish a new TME-targeting precision medicine platform for this incurable disease.

The GLIORESOLVE Consortium includes academics, clinicians, private sector and not-for-profit partners, bringing together exceptional experience and state-of-the-art facilities. All members of the consortium are involved in PhD candidate training and all PhD candidates enrolled in the GLIORESOLVE programme will have the opportunity to work in both academic and non-academic sectors. 

To get more information please click here